What is Medicover AB (publ) (MCVEY)?

Medicover AB (publ) (MCVEY) is a stock in the Healthcare sector, Medical - Care Facilities industry. View full analysis on Stocks360.

What is the current price of MCVEY?

The current price of MCVEY is $16.55. Prices are updated in real time on Stocks360.

What is MCVEY's price-to-earnings (PE) ratio?

MCVEY's trailing twelve-month PE ratio is 45.87, based on current price and earnings per share data available on Stocks360.

What is MCVEY's market capitalization?

MCVEY's market capitalization is $2,515,174,135.00, placing it in the mid-cap tier.

Does MCVEY pay a dividend?

Yes. MCVEY has a trailing twelve-month dividend yield of 0.01%. Dividend data is sourced from financial market providers and displayed on Stocks360.

Medicover AB (publ) (MCVEY)

Stock analysis · OTC · Healthcare · Medical - Care Facilities

$16.55

Market Cap

$2.52B

PE (TTM)

45.87

EPS (TTM)

N/A

Dividend Yield

0.78%

Beta

1.59

Day Range

$16.55 – $21.54

52-wk Range

$16.55 – $21.54

Avg Volume

N/A

Volume

100.00

Medicover AB (publ) (MCVEY) is a publicly traded company in the Healthcare sector. Latest price: $16.55. Market cap $2.52B. Trailing PE 45.87. Dividend yield 0.78%. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

You have viewed 7 SEO analysis pages

Unlock saved watchlists, personalized setups, and referral credits with a free Stocks360 account.

Continue with free signup

1-Year Price

2025-10-31 · $16.55 2026-10-26 · $16.55 (+0.00%)

Proprietary Signals

Signal snapshot temporarily unavailable.

About Medicover AB (publ)

Medicover AB (publ), established in Stockholm, Sweden in 1995, operates as a comprehensive provider of healthcare and diagnostic services throughout a dozen countries, including Germany, Sweden, Poland, Turkey, Belarus, Bulgaria, Georgia, Hungary, Serbia, Moldova, Ukraine, and India. The company's operations are distinctly categorized into two segments: Healthcare Services and Diagnostic Services. Within its Diagnostic Services arm, Medicover performs an extensive array of laboratory analyses. These span various specialties, encompassing tests for allergies and autoimmune conditions, infectious agents (bacteriology, parasitology, microbiology), biochemical and immunological markers, blood grouping and transfusion requirements, tumor detection, clinical chemistry, cellular and tissue pathology (cytology, haematology, histopathology), human genetics, hygiene, molecular biology, and pharmacological/toxicological screenings. This substantial diagnostic infrastructure includes 97 clinical laboratories, 733 blood collection points, and 26 specialized clinics, operational across 10 of its countries of presence. Complementing this, the Healthcare Services division features a broad network…

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	45.87×
P/S (TTM)	1.58×
P/B	7.26×
PEG	0.49×
P/FCF (TTM)	22.26×
EV / EBITDA	13.32×
EV / Sales	2.13×
Earnings Yield	2.19%
Free Cash Flow Yield	4.49%
Dividend Yield	0.78%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$5.28B
Revenue (TTM)	$2.47B
Net Income (TTM)	$85.30M
Free Cash Flow (TTM)	$223.38M
Net Debt	$1.37B
Working Capital	-$433.60M
Gross Margin	23.37%
Operating Margin	7.13%
Net Margin	3.44%
Return on Equity	16.01%
Return on Invested Capital	6.28%